Pharmacy

Risk of Incident Gout Following Exposure to Recombinant Zoster Vaccine in Us Adults Aged >50 years

Adult woman doctor sitting at table holding a tablet consulting a senior man

To assess whether recombinant zoster vaccine (RZV) is associated with an increased risk of new-onset gout among US adults aged ≥50 years.

Read more:  ScienceDirect